Source: UNIVERSITY OF FLORIDA submitted to NRP
COMBATING ANTIBIOTIC RESISTANCE
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1017902
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Oct 2, 2018
Project End Date
Sep 30, 2023
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
UNIVERSITY OF FLORIDA
G022 MCCARTY HALL
GAINESVILLE,FL 32611
Performing Department
Microbiology and Cell Science
Non Technical Summary
Targeting bacteria with conventional antibiotics eventually leads to the emergence of resistance. In addition, the development of novel antibiotics has almost completely ceased. With the increasing antibiotic resistance and limited treatment options bacterial infections are once again becoming untreatable, leaving a disastrous socio-economical footprint on humans. High-priority pathogens, known as the ESKAPE pathogens:Enterococcus faecium,Staphylococcus aureus,Klebsiella pneumoniae,Acinetobacter baumannii,Pseudomonas aeruginosa,andEnterobacterspecies are the leading cause of death from hospital-acquired infections claiming 23,000 deaths in the United States each year. It is estimated that by 2050 this number will increase 10 times. The ESKAPE pathogens are considered to be extracellular and are cleared by the host immune cells. Therefore, these pathogens do end up in the intracellular environment of various phagocytic cells, including macrophages, dendritic cells, or neutrophils. While the immune system is able to clear these pathogens, the clearance is not effective in immunocompromised individuals. Our current understanding of the mechanisms involved in the detection and clearance of these bacteriain vivois very limited. For example, only recently we have learned about the virulence of these bacteria in the context of phagocytic cells.With the increase of antibiotic resistance and limited availability of effective antibiotics, the development of new antimicrobial approaches is crucial to maintain human and animal health and prevent further spread of global antibiotic resistance. As such, we have been adapting a host-targeting approach by engineering host immune cells to attain a therapeutic and a prophylactic effect against infections caused by Gram-negative ESKAPE bacteria, namelyA. baumannii,K. pneumoniae, andP. aeruginosa. We have pioneered this approach using typical intracellular bacteria and have a strong evidence of its success against multidrug-resistant (MDR) Gram-negative bacteria.Finally, we will explore mechanisms involved in the transmission of antibiotic resistance genes across bacteria usingC. elegansintestine as a test tube. Understanding antibiotic resistance transmission in the context of a simple model will provide new avenues to develop a novel line of drugs that inhibit transmission of antibiotic resistance.The importance of this project is underlined by a desperate need to develop, alternative to antibiotics, treatment options that will prevent and treat infections by MDR bacteria and inhibit the spread of antibiotic resistance. The results of this project can have a direct and immediate application not only in healthcare, but also in farm animals where the problem of antimicrobial resistant infections is constantly increasing. This research proposal falls at the center stage of my laboratory's long-term goals to identify and develop novel host-targeting prophylactics and therapeutics for bacterial infections.
Animal Health Component
(N/A)
Research Effort Categories
Basic
50%
Applied
(N/A)
Developmental
50%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7224010103020%
7224010104020%
7224010110020%
7224010109020%
7224010106020%
Goals / Objectives
The major goal of this project is to develop a novel host-targeting approach to treat bacterial infections and prevent the spread of antibiotic resistance. Currently, all antibiotic-based therapies against bacteria are losing battle against rapid development of resistance. Moreover, the development of novel antimicrobial agents has almost completely ceased. With the increasing resistance and lack of treatment options bacterial infections are once again becoming a serious threat to the public. As such, my research objectives are to:I-1. Engineer phagocytic immune cells to enhance their ability to uptake and kill bacteria using pharmacological and genetic approachesI-2. Characterize mechanisms of actionI-3. Establish the efficacy of the engineered immune cells usingin vivoanimal modelII-1. Develop aC. elegansmodel to study horizontal gene transfer (HGT)II-2. Assess the effect of antibiotics on the polymicrobial colonization of the C. elegans intestine and identify their effect on the organismal biologyII-3. Screen for small-molecule inhibitors of HGT usingC. elegansWhen successfully completed, each of these objectives will broaden our understanding of antibiotic resistance and will provide novel ways to target antibiotic resistant bacteria.
Project Methods
Unlike conventional antimicrobial therapies that target bacteria directly, host-targeting approach can enhance the organismal ability to kill bacteria by: (i) enhancing the uptake of bacteria by phagocytic host cell, (ii) intercepting host pathways or nutrients utilized by the pathogen during infection, and (iii) enhancing the ability of the host cell to kill bacteria. Direct targeting of the host, as opposed to bacteria, to enhance its ability to clear infections can be an attractive strategy to target antibiotic-resistant strains of bacterial pathogens. Hence,I hypothesize that the host-targeting approach can circumvent antibiotic resistance and provide a novel effective and alternative to antibiotics treatment option. To test this hypothesis, my laboratory will use pharmacological means to engineer immune cells at each of the three majorsteps: bacterial entry, availability of nutrients and metabolic intermediates, and cellular ability to kill bacteria. The identified candidates will be tested using a cell-based immunotherapy. I have establishedin vitroand invivoinfection models usingA. baumannii,K. pneumoniae, andP. aeruginosa. Moreover, I have developed a new method of enumerating intracellular bacteria that, unlike conventional plating for colony forming units (CFUs), can be used in high-throughput screens. The method is based on measuring the detection time at which a change in the fluorescent signal from growing bacteria is initially detected (detection time, dT). The dT is proportional to the number of initially inoculated bacteria. The higher the dT, the lower the initial number of inoculated bacteria. Using such approach even the slightest difference in the initial number of bacteria can be detected with higher sensitivity than CFU plating method. We will use this method to screen for small molecule mediators of bacterial entry and enhancers of macrophage-mediated killing. Finally, I have developed a cell-based immunotherapy where bone marrow-derived murine macrophages (BMDMs) are injected intoinfected mice leading to a significant increase in the survival, improvement of clinical manifestation, and a systemic decrease ofbacterial load across all organs. These results indicate that such cell-based immunotherapy provides a promising antimicrobial treatment. Enhancing the ability of macrophages to kill bacteria can improve the efficacy of this cell-based approach; however, we lack enhancers of bacterial killing. The proposed project will utilize this approach to assess the efficacy of the indentified small molecule enhancers of bacteria clearance.Human gut microbiota is a complicated "organ" that harbors estimated 100x more genes compared to the human genome. Bacterial populations within the gut are thought to be the reservoir for antibiotic resistance. However, because of the complexity of the polymicrobial communities in the human gut, the microbiota antibiotic resistance is not well understood. We are proposing a minimalistic approach to study polymicrobial interaction and their effect on the host using the C. elegans intestine. C. elegans is an established model organism that has been successfully utilized in the study of microbial colonization, pathogenicity, immunity, and other processes. The C. elegans intestine is a 20-cell organ made up of eight segments with a lumen that is the site of bacterial colonization. Surprisingly, it shares many similarities with the human intestinal epithelium. Moreover, this nematode is a facultative anaerobe and can survive under anoxic growth conditions, providing an ideal environment to study microbes, especially obligate anaerobes that colonize the human gut. We aim to utilize C. elegans intestine as a test tube to study transmission of antibiotic resistance among bacterial communities and identify their inhibitors.

Progress 10/01/20 to 09/30/21

Outputs
Target Audience:Scientific community and students Changes/Problems:There are no changes in addition to what was emphasized during the previous reporting period. What opportunities for training and professional development has the project provided?Principal Investigator: IPEC Faculty Development Institute: Building a Framework for Interprofessional Education for Collaborative Practice & Health Equity (2021) University of Florida: Diversity and Inclusion Workshop (2021) Annual NIAMRRE Conference Planning Committee (University of Nebraska - Lincoln) (2021) Southeastern/Florida Branch American Society for Microbiology Awards Committee (2021) Southeastern Branch of the American Society for Microbiology Policy Committee Member (2021) National Institute of Antimicrobial Resistance Research and Education, Chair of the Advisory Council (2021) National Institute of Antimicrobial Resistance Research and Education, Vice-Chair of the Advisory Council (2020) ? Students: Dr. Czyz serves on nine graduate student committees. He actively trains and mentors undergraduate and graduate students Michael Butcher was selected for the University Scholar Program to continue research on phages in the Czyz lab (2021-2022). Autumn Dove, a graduate student, received a first-place Graduate Outstanding Poster Talk at the FL/SEB ASM Virtual Join Meeting. March 26, 2021. Alyssa Walker, a graduate student, received a first-place Graduate Presentation at the North Central Florida Chapter of the Society for Neuroscience. Alyssa C Walker, Alfonso S. Vaziriyan-Sani, Emily T. Donahue, Rohan Bhargava, Autumn S. Dove, Keelnatham T. Shanmugam, Daniel M. Czy?. Colonization of the C. elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. North Central Florida Society for Neuroscience Virtual Chapter Conference. Abstract/Poster. February 19, 2021. How have the results been disseminated to communities of interest?The results have been disseminated through scientific meetings, conferences, and publications. What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period, we anticipate determining the mechanisms by which bacteria (and possibly their products) affect host protein folding homeostasis. Furthermore, we anticipate on determining the mechanisms of one of the inhibitorsof bacterial uptake that we are working on.

Impacts
What was accomplished under these goals? The Czyz Laboratory finished a screen of 2,400 approved drugs for ones that target phagocytic cells and either enhance or inhibit the uptake of E. coli. We are currently working on determining the mechanisms by which the identified small-molecules modulator of bacterial uptake function. Additionally, we are currently deciphering the effect by which bacteria from the gut microbiome affect protein folding upon colonization of the C. elegans intestine. We finished screening all culturable isolates from the Human Microbiome Project and found bacteria that are beneficial (suppress toxic protein aggregation) and detrimental (enhance toxic protein aggregation). Characterizing the effect of gut residents on protein folding could potentially reveal new diagnoses, prophylactics, and therapeutic approaches against protein conformational diseases.

Publications

  • Type: Journal Articles Status: Accepted Year Published: 2021 Citation: Walker CA, Rohan Bhargava, Vaziriyan-Sani AS, Donahue ET, Bhargava R, Dove AS, Gebhardt MJ, Czyz DM. Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. 2021. PLOS Pathogens.
  • Type: Journal Articles Status: Accepted Year Published: 2021 Citation: Vaziriyan-Sani AS, Handy RD, Walker AC, Pagolu CN, Enslow SM, Czy? DM. Automating Aggregate Quantification in Caenorhabditis elegans. J Vis Exp. 2021;(176):10.3791/62997. Published 2021 Oct 14. doi:10.3791/62997
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: Alyssa C Walker, Alfonso S. Vaziriyan-Sani, Emily T. Donahue, Rohan Bhargava, Autumn S. Dove, Keelnatham T. Shanmugam, Daniel M. Czy?. Colonization of the C. elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. Midwest Stress Response and Molecular Chaperone Meeting. Abstract/Poster. January 16, 2021.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: *Alyssa C Walker, Alfonso S. Vaziriyan-Sani, Emily T. Donahue, Rohan Bhargava, Autumn S. Dove, Keelnatham T. Shanmugam, Daniel M. Czy?. Colonization of the C. elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. North Central Florida Society for Neuroscience Virtual Chapter Conference. Abstract/Poster Talk. February 19, 2021.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: Alyssa C Walker, Alfonso S. Vaziriyan-Sani, Emily T. Donahue, Rohan Bhargava, Autumn S. Dove, Keelnatham T. Shanmugam, Daniel M. Czy?. Colonization of the C. elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. Emerging Pathogen Institute Day. University of Florida, Gainesville, Florida. Abstract/Poster Talk. February 25, 2021.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: Autumn S Dove, Rohan Bhargava, Alyssa C Walker, Maegawa GHB, Daniel M Czyz. Drug Repurposing Screen for Anti-infectives Identifies Quinacrine as an Intracellular Host-targeted Antibiotic. Emerging Pathogen Institute Day. University of Florida, Gainesville, Florida. Abstract/Poster Talk. February 25, 2021.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: *Dove A, Walker AC, Maegawa GHB, Czyz DM. Drug repurposing screen for anti-infectives identifies quinacrine as an intracellular host-targeted antibiotic. Southeast Branch/Florida ASM Meeting. Abstract/Poster Talk. March 26, 2021. Virtual Meeting.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: Alyssa C Walker, Rohan Bhargava, Alfonso S. Vaziriyan-Sani, Christine Pourciau, Emily T. Donahue, , Autumn S. Dove, Michael M. Gebhardt, Garrett Ellward, Tony Romeo, Daniel M. Czy?. Colonization of the C. elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. World Microbe Forum. Abstract/Poster Talk. June 20-24, 2021.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: *Dove A, Walker AC, Maegawa GHB, Czyz DM. Drug repurposing screen for anti-infectives identifies quinacrine as an intracellular host-targeted antibiotic. World Microbe Forum. Abstract/Poster Talk. June 20-24, 2021.
  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2021 Citation: Daniel Czyz. Deciphering the effect of bacteria on protein conformational diseases. 2021 New Investigator in Alzheimers Disease Meeting. American Federation of Aging Research. Talk/Virtual. October 4, 2021.


Progress 10/01/19 to 09/30/20

Outputs
Target Audience: Nothing Reported Changes/Problems:One of the major changesto the project is the direction of aim two. Instead of studying horizontal gene transfer, I focused more on studying the effect of bacteria on protein folding homeostasis (II-2). What opportunities for training and professional development has the project provided?I have attended a semester-long CTSI Mentor Academy and multiple faculty development programs, including Developing Grant Portfolio. Additionally, I mentored and supervised four graduate students and ten undergraduate students. How have the results been disseminated to communities of interest?Both the PI, graduate and undergraduate students have been disseminating research findings through attending and presenting at meetings and conferences. What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period, I plan to complete screening 2,400 drugs for modulators of bacterial uptake and begin employing the C. elegans model in the study of host-bacteria interaction.

Impacts
What was accomplished under these goals? We began screening a library of 2,400 approved drugs for those that specifically target human phagocytic cells to modulate their activity to uptake bacteria. Such an immunomodulatory approach has the potential to enhance the uptake of common extracellular bacteria and inhibit cellular entry by common intracellular bacterial pathogens. We are currently continuing the screen. In addition, we established a C. elegans model to study the effect of bacteria on the protein folding environment. This project is also ongoing during this reporting period.

Publications

  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: 25th Annual Midwest Stress Response and Molecular Chaperone Meeting. Northwestern University, Evanston, IL. Butyrate Suppresses Bacteria-induced Protein Aggregation in C. elegans Models of Protein Conformational Diseases. January 18, 2020.
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: *Autumn S Dove, Rohan Bhargava, Alyssa C Walker, Maegawa GHB, Daniel M Czyz. A macrophage-based screen yields host-targeting modulators of bacterial uptake. National Institute of Antimicrobial Resistance Research and Education Knowledge Exchange Virtual Poster Session. Abstract/Talk/Poster. July 31, 2020.
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: *Rohan Bhargava, Mark G Gorelik, Alyssa C Walker, Tony Romeo, Daniel M Czyz. Identifying butyrogenic bacteria in the human microbiome. National Institute of Antimicrobial Resistance Research and Education Knowledge Exchange Virtual Poster Session. Abstract/Talk/Poster. July 30, 2020.
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: Walker A, Dove A, Donahue E, Vaziriyan-Sani A, Hoffman BJ, Dove A, Shanmugam KT, Czyz DM. Butyrate suppresses bacteria-induced protein aggregation in C. elegans models of protein conformational diseases. Southeast Branch ASM Meeting. Abstract/Poster/Talk. February 22, 2020. University of Alabama, Huntsville, Alabama
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: Dove A, Maegawa GHB, Czyz DM. Identification of host-targeting modulators of bacterial uptake using a novel assay for quantifying intracellular bacteria. Southeast Branch ASM Meeting. Abstract/Talk. February 21, 2020. University of Alabama, Huntsville, Alabama
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: Walker A, Dove A, Donahue E, Vaziriyan-Sani A, Hoffman BJ, Dove A, Czyz DM. Butyrate suppresses bacteria-induced protein aggregation in C. elegans models of protein conformational diseases. Emerging Pathogen Institute Day. Abstract/Poster. February 7, 2020. University of Florida, Gainesville, Florida
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: Dove A, Walker A, Maegawa GHB, Czyz DM. A macrophage-based screen yields host-targeting modulators. Emerging Pathogen Institute Day. Abstract/Poster. February 13, 2020. University of Florida, Gainesville, Florida
  • Type: Conference Papers and Presentations Status: Other Year Published: 2020 Citation: Walker A, Donahue E, Vaziriyan-Sani A, Dove A, Hoffman BJ, Shanmugam KT, Czyz DM. Butyrate Suppresses Bacteria-induced Protein Aggregation in C. elegans Models of Protein Conformational Diseases. Abstract/Poster/Talk. January 18, 2020. 25th Annual Midwest Stress Response and Molecular Chaperone Meeting. Northwestern University, Evanston, Illinois


Progress 10/02/18 to 09/30/19

Outputs
Target Audience:-The target audience of the proposed work are individualsaffected by bacterial infections and protein conformational diseases (i.e. Alzheimer's disease, Parkinson's disease, ALS, Huntington's disease, etc). -During the funding period, the PI also developed and taught a course on antimicrobial resistance to undergraduate and graduate students. Changes/Problems:We have changed part II of the project. Instead of studying horizontal gene transfer in the C. elegans gut, we began working on the effect of bacteria on their host.Recent discoveries demonstrate that bacteria contribute to the pathogenesis of protein conformational diseases. However, the identities of bacteria that influence protein folding in their host and the underlying mechanisms by which this influence is executed remain largely unknown. We began deciphering the role of pathogenic bacteria that reside in the human gut on host proteostasis using the C. elegans intestine. We found that opportunistic pathogens often associated with gastroenteritis--including members of the Enterobacteriaceae family and other species such as Listeria, Vibrio, Pseudomonas, and Acinetobacter--enhanced protein aggregation upon colonization of the intestine. Interestingly, these bacteria not only disrupt the protein folding environment in the host intestine, but also in neurons and muscle tissue. Furthermore, we observed that colonization of the C. elegans intestine with proteostasis disrupting bacteria enhanced protein aggregation in the F1 generation. Taken together, these data suggest that bacteria may release "signals" that affect distal tissues, including the gonad. Many commensal bacteria produce short-chain fatty acids; among these molecules, butyrate was recently shown to mitigate the severity of protein conformational diseases. We found that butyrate enhanced bacteria-mediated protein aggregation at low physiological concentrations but suppressed bacteria-induced aggregation at high therapeutic concentrations. To examine the effect of butyrate-producing bacteria on host proteostasis, we colonized the C. elegans intestine with bacteria engineered to overproduce butyrate. The resulting increase in endogenous butyrate enhanced proteostasis in the intestine and other tissues, as assessed by a decrease in protein aggregation in the host. Collectively, our results demonstrate that pathogenic enteric bacteria disrupt host proteostasis and enhance aggregation of metastable proteins. These findings suggest that dysbiosis between commensal butyrate-producing bacteria and pathogenic enteric species may have a detrimental effect on host proteostasis. What opportunities for training and professional development has the project provided?-The project helped to train ten undergraduate students (Heelesh Bapatla, Alfonso Vaziriyan-Sani, Shelby Harding, Lillianne Marcheggiani, Nelson Gonzalez, Emily Herring, Troy Benvenuto, Adrienne Hernandez, Emily Donahue, and Natalia Andraka). Six of these students havesince graduated and moved onto medical or professional schools. -Alyssa Walker joined the lab as an MS student and switched her degree program to PhD -Autumn Dove joined the lab as a PhD student and works full time on the host-directed antimicrobials project -Both Alyssa and Autumn presented their work at the 2019 UF Emerging Pathogen Institute Day and at departmental retreats. -Alfonso Vaziriyan-Sani was an undergraduate student volunteering in the lab. During the Summer of 2019, he received a Summer Internship to work full time. Alfonso has been in the lab for the past two years and he will continue to work on a Master's degree in the Czyz Lab. -Adrienne Hernandez and Troy Benvenuto, both undergraduate students, received an NSF/USDA S-STEM Summer Undergraduate Research Experience funding (2019). Since then, Troy has graduated and Adrienne continues to volunteer in the lab. All students were expected to participate in scientific research guided by their mentor graduate students and supervised by the Principal Investigator. How have the results been disseminated to communities of interest?-During the 2018-2019 reporting period, the project was still in its developmental stage. Therefore, there were not too many results to disseminate. Nonetheless, Alyssa Walker and Autumn Dove presented their work at a Departmental Retreat and at the UF Emerging Pathogen Institute Day. What do you plan to do during the next reporting period to accomplish the goals?-Both Alyssa Walker and Autumn Dove are finishing up their experiments for their first publications. The goal for 2019-2020 period is to complete phase I of each project and publish the results. Each student will begin mechanistic studies to understand the mechanisms of action of drugs that modulate bacterial uptake and the mechanisms involved in the bacteria-mediated modulation of protein homeostasis

Impacts
What was accomplished under these goals? -We have developed a novel assay to assess intracellular bacteria -Using this new assay, we began screening 2,400 FDA-approved drugs for the ones that either enhance or suppress phagocytic immune cell-mediated uptake of bacteria -We developed C. elegans models of bacterial colonization that allow us to study host-bacterial interaction -We have demonstrated that pathogenic antibiotic-resistant enteric bacteria disrupt host protein homeostasis leading to toxic protein aggregation

Publications

  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Dove A, Walker A, Czyz DM. Host-targeted Approach Against MDR Gram-negative Bacteria. Emerging Pathogen Institute Day. Abstract/Poster. February 7, 2019. University of Florida, Gainesville, Florida Walker A, Dove A, Hoffman BJ, Czyz DM. The effect of human gut microbiota on the organismal proteostasis. Emerging Pathogen Institute Day. Abstract/Poster. February 7, 2019. University of Florida, Gainesville, Florida